PRNAF - Alterity Therapeutics Ltd (ATHE) CEO David Stamler on Q2 2021 Results - Earnings Call Transcript

Alterity Therapeutics Ltd (ATHE) Q2 2021 Earnings Conference Call February 25, 2021, 17:00 ET Company Participants David Stamler - CEO, Chief Medical Officer & SVP, Clinical Development Kathryn Andrews - CFO Conference Call Participants Presentation Operator Good morning, and welcome to the Alterity Therapeutics H1 Financial Results and Business update. [Operator Instructions]. Today's call is being recorded. And I'd like to introduce you to our host, Dr. David Stamler, Alterity Therapeutics Chief Executive Officer. He is joined by Mr. Geoffrey Kempler, Founder and Chairman; and Ms. Kathryn Andrews, the company's Chief Financial Officer. Over to you, Dr. Stamler. David Stamler Well, thank you, Greg. Good morning to our investors in Australia, and good afternoon to our investors here in the United States. Thank you for joining our call to discuss the first half year financial results and, more importantly, as a development stage company, our progress during the 6 months

For further details see:

Alterity Therapeutics Ltd (ATHE) CEO David Stamler on Q2 2021 Results - Earnings Call Transcript